Core B- The Developmental (Dev) Core of the San Diego (SD) CFAR aims to support emerging investigators and promote innovative directions in HIV research. The Dev Core provides opportunities for junior investigators and investigators new to HIV research to generate preliminary data for larger grant applications through the awarding of pilot grants (up to $50K for 1 year). Developmental grants are also employed in the recruitment and retention of new HIV research faculty, who can in many cases apply for funding prior to their arrival. Applications are evaluated by the Developmental Grant Review Committee which represents a broad range of HIV research expertise and all four SD CFAR member institutions. In addition, two new categories of grant opportunities available to post-doctoral fellows (Next Generation Grants, up to $10K) and junior faculty with impending NIH R series grant applications (High Impact MicroGrants, up to $3K) are now offered to further leverage CFAR funding to assist these investigators in establishing productive HIV research careers. The Dev Core also collects data on the success of grant awardees in terms of resultant publications, additional grant funding, and career advancement. The Dev Core further cultivates the community of emerging HIV researchers through Training Workshops, seminars and formal mentorship opportunities. These include weekly Work-in-Progress, Journal Club and AIDS Clinical Rounds, mock NIH-style study section reviews for K and R series grant applications (OK Review), and a Leadership Academy where junior faculty are mentored and operate as CFAR Core co- directors. These programs facilitate the academic success of emerging researchers and prepare them for leadership roles. Finally, the Dev Core operates a Rapid Review Board for the efficient solicitation and review of applications for funding opportunities with quick turnaround times, such as certain foundation grants and Administrative Supplements. This Rapid Review Board identifies appropriate mentors for the applicants, provides constructive feedback, and in cases where there are limits on the number of applications, determines which applications are most likely to be successful. With the growth of the SD CFAR, the Dev Core can expand the number of innovative projects and training opportunities that it supports and more effectively cultivate the next generation of talented HIV investigators.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California, San Diego
La Jolla
United States
Zip Code
White, Cory H; Beliakova-Bethell, Nadejda; Lada, Steven M et al. (2018) Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol 9:603
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Innes, Steve; Patel, Kunjal (2018) Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS 13:187-195
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79
Christensen-Quick, Aaron; Chaillon, Antoine; Yek, Christina et al. (2018) Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy. J Acquir Immune Defic Syndr 79:e104-e107
Ben Hamida, Amen; Rafful, Claudia; Jain, Sonia et al. (2018) Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. J Urban Health 95:83-90
Dillon, Stephanie M; Guo, Kejun; Austin, Gregory L et al. (2018) A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS 32:1599-1611
Groessl, Erik J; Ganiats, Theodore G; Hillery, Naomi et al. (2018) Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis 18:102

Showing the most recent 10 out of 921 publications